Theralase Technologies Inc. conducts research and development and markets its products in both Canada and the United States.
4 reports, 3 independent
Updated Jun 30
Gone quiet
- Reports
- 4
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Theralase Technologies Inc. conducts research and development and markets its products in both Canada and the United States.
How it developed
Newest first. Tap a step to see who reported it.- Theralase is utilizing Ruvidar variants for cancer treatment, supported by Quantum simulation and Algorithmiq's design pipeline.Sub-event
Theralase Technologies Inc. (based in Toronto) filed its prospectus with Canadian authorities.1 source
Theralase Technologies Inc. operates in the US and Canada, focusing on R&D and product marketing.1 source